Clinical trials
Phase 2 Leukemia, Lymphocytic, Chronic, B-Cell trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 2 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 3 |
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 3 |
| 2013 | 2 |
| 2015 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Terminated | 5 |
| Active, not recruiting | 2 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alliance for Clinical Trials in Oncology | 2 |
| Biogen | 2 |
| NCIC Clinical Trials Group | 2 |
| University Health Network, Toronto | 2 |
| AbbVie | 1 |
| British Columbia Cancer Agency | 1 |
| Canadian Cancer Trials Group | 1 |
| CancerCare Manitoba | 1 |
| Celgene | 1 |
| Eisai Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Lymphocytic, Chronic, B-Cell | 24 |
| Lymphoma, Follicular | 5 |
| Leukemia | 4 |
| Lymphoma | 4 |
| Lymphoma, Mantle-Cell | 4 |
| Lymphoma, Non-Hodgkin | 3 |
| Recurrence | 3 |
| Burkitt Lymphoma | 2 |
| Lymphoma, B-Cell, Marginal Zone | 2 |
| Lymphoma, Large B-Cell, Diffuse | 2 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.